FEN1 and breast carcinoma: This study examined the effects of the FEN1 inhibitor FEN1-IN-4 on breast cancer cell lines including four TNBC cell lines and whether it is a useful therapeutic agent in breast cancer therapy in monotherapy or in combination with IR.